WAVEMAN · COMPANY

KRMD · Koru Medical Systems, Inc.

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475

← ALL COMPANIES

KRMD

Name: KORU Medical Systems, Inc. (KRMD) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

KORU Medical Systems, Inc.

MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0000704440

CLUSTER · 5 INSIDERSC-SUITE BUYING · 5FORM 144 · 1☆ WATCH

INSIDER NET · 180D

$1.5M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+22.2%

XBRL, annual

NET MARGIN

-6.4%

CONVERSIONS · 180D

codes C/M, not in net · $0 priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$1.5M over 180 days

+$49.3K over 90 days

more than 94% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

44 funds added or opened last quarter

below 64% of Medical Devices

REVENUE

+22.2% year over year

more than 78% of Medical Devices

MARGIN

-6.4% net margin

more than 54% of Medical Devices

BUYBACKS

no share repurchases reported

SHORT

1.7% of shares outstanding short · 5.5 days to cover · settled 2026-07-31

below 67% of Medical Devices

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

5 insiders bought a net $1.5M while the stock fell 32% over six months, but 1 Form 144 notice ($108.6K) are queued to sell.

44 funds added or opened positions in the latest 13F quarter, of 87 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -19.7%

-19.7%12M

INSIDER BUYFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

5 insiders reported buying shares.

The record shows a net $1.5M bought by insiders over 180 days, 44 funds added last quarter, $108.6K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, KORU Medical Systems, Inc. insiders bought a net $1.5M of stock across 20 Form 4 purchases and sales, with 5 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER

FILED

VALUE

KALBERMATTEN ADAM R

President-Chief Commercial Off

BUY

2026-06-11

7,500.0

$29.5K

KALBERMATTEN ADAM R

President-Chief Commercial Off

BUY

2026-06-11

5,000.0

$19.8K

Schiller Eric

Chief Technology Officer

BUY

2026-05-18

5,000.0

$19.6K

Tharby Linda M

Chief Executive Officer

BUY

2026-05-15

1,191.0

$4.7K

Tharby Linda M

Chief Executive Officer

BUY

2026-05-15

1,191.0

$1.4M

20 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 15 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

First Light Asset Management, LLC

3,387,902.0 sh

$14.2M

Topline Capital Management, LLC

3,373,842.0 sh

$14.2M

BlackRock, Inc.

2,628,352.0 sh

$11.0M

VANGUARD CAPITAL MANAGEMENT LLC

1,818,121.0 sh

$7.6M

GEODE CAPITAL MANAGEMENT, LLC

1,128,096.0 sh

$4.7M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

KALBERMATTEN ADAM R

FILED 2026-08-03

$108.6K

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Ultra-Small Company Fund

$325.3K POSITION · AS OF 2026-03-31

0.4%

ACUITAS US MICROCAP FUND

$245.9K POSITION · AS OF 2026-03-31

0.3%

SIIT SMALL CAP II FUND

$333.7K POSITION · AS OF 2026-02-28

0.1%

SIMT Tax-Managed Small/Mid Cap Fund

$763.7K POSITION · AS OF 2026-03-31

0.1%

U.S. Small Cap Equity Fund

$106.6K POSITION · AS OF 2026-03-31

0.1%

iShares Micro-Cap ETF

$470.9K POSITION · AS OF 2026-03-31

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Clinical pipeline

ClinicalTrials.gov · 1 registered trials, 1 still enrolling or running — a status change here is dated weeks before the press release

Not applicable

1 ACTIVE

TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED

Executive pay vs shareholder return · Linda Tharby

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2025

$1.7M

$3.2M

$1.8M

+63%

—

2024

$1.3M

$1.9M

$598.9K

+8%

—

2023

$713.4K

-$1.2M

$547.3K

-31%

—

2022

$962.6K

$1.4M

$841.7K

+19%

—

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$41.1M	$33.6M	$28.5M	$27.9M
GROSS PROFIT	$25.6M	$21.3M	$16.7M	$15.4M
OPERATING INCOME	$-3.0M	$-6.4M	$-10.3M	$-10.8M
NET INCOME	$-2.6M	$-6.1M	$-13.7M	$-8.7M
EPS (DILUTED)	-0.06	-0.13	-0.30	-0.19
OPERATING CASH FLOW	$462.4K	$-319.7K	$-4.9M	$-5.4M
CASH	$8.9M	$9.6M	$11.5M	$17.4M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-04 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE